BioSpace News Archive

Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today provides a clinical update and focus for its Oncoprex™ immunogene therapy program for 2020, prioritizing the development of Oncoprex in combination with osimertinib for the treatment of non small cell lung cancer.

The Campbell Institute at the National Safety Council is proud to announce six new member organizations dedicated to world class environment, health and safety practices.

Feb. 5, 2020 15:00 UTC -- VYONDYS 53™ is the second RNA exon-skipping treatment for DMD approved in the U.S. -- -- Orsini Pharmaceutical Services is a select dispensing pharmacy for Sarepta’s DMD products EXONDYS 51® (eteplirsen) and VYONDYS 53™ (golodirsen) --

Business Activity Index at 60.9%; New Orders Index at 56.2%; Employment Index at 53.1%

Walgreens Boots Alliance, Inc. announced the appointment of Richard Ashworth as President of Walgreens.

Cannabis Science and Technology™—a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction, and cultivation—is proud to announce the addition of William Z. Levine, D.D.S., to its editorial advisory board.

Feb. 5, 2020 16:30 UTC Blood Test Accurately Identifies HPV-related Head and Neck Cancer Recurrence; Prospective Clinical Study Published in Journal of Clinical Oncology Naveris, Inc. to provide NavDx ® blood test to Cancer Centers of Excellence WALTHAM, Mass.--( BUSINESS WIRE )-- A novel blood test can detect recurrent Human Papilloma Virus (HPV)-related head and neck (oropharyngeal) cancers, according to a study published online in the Journal of Clinical Oncology b

California Senate Bill 793 would prohibit menthol cigarettes and many vaping products

Alydia Health, a clinical-stage medical device company dedicated to making childbirth safer for all mothers, today announced that the company has completed enrollment in the pivotal PEARLE IDE Study

Utilizing NowPow’s platform, community-based organizations will connect patients to available services that are traditionally fragmented and difficult to navigate